Schedule 13G ownership disclosure

Sonoma Pharmaceuticals Inc

Security class unavailable · CUSIP: 83558L105

Event date: 2018-03-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
571,428
Percent of class
9.2600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-016307
Form type
SC 13G
Filer
Montreux Equity Partners V, L.P.
CIK
CIK 1548152
Filed
Mar 09, 2018
Reporting period
Mar 02, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub